Beta-cyclodextrin remains the most widely produced and commercially used form, largely because of its favorable cavity size, relatively low production cost, and well-documented safety profile.

A new class of beta blockers designed to activate only when struck by specific wavelengths of light could allow doctors to ...

Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way ...

monday.com Ltd. (NASDAQ:MNDY) is one of the 11 best software application stocks to buy now. On March 11, monday.com Ltd.

On March 17, Orlando Bravo, Founder and Managing Partner of private equity firm Thoma Bravo, spoke with CNBC about the impact ...

As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and ...

In interviews with business leaders across industries, AI Monster ( founders repeatedly heard the same frustrations from their peers:-- "AI courses are sort of us ...

Endogenex today announced new findings supporting its technology for improving outcomes in individuals with type 2 diabetes.

Fed up with the random nature of generative AI? Adobe Firefly’s new Custom Models seek to change that by learning your own ...

It's my pleasure to be moderating this chat with the CEO of Voyager Therapeutics, Al Sandrock, who sure many folks know well from his current role and famous roles as prior. Al, maybe we can get into ...

Dan Durn is auto-responding to 300,000 emails, slashing contract review times, and stress-testing earnings messaging with AI.

A team led by neurobiologist Prof. Dr. Hilmar Bading at Heidelberg University has identified a key molecular process that drives the progression of ...